LeafNLP Demos
Back to explore

Report #2886413

Received Feb 23, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
GA
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (1)

Erythema

Symptom narrative

Redness; This non-serious case was reported by a physician via sales rep and described the occurrence of erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced erythema (Verbatim: Redness). The outcome of the erythema was resolved. The reporter considered the erythema to be related to Shingrix. The company considered the erythema to be related to Shingrix. Additional Information: GSK Receipt Date: 29-JAN-2026 The batch number was not provided and a request for this information has been made.